Megaclox Capsule contains a combination of Ampicillin 250 mg and Cloxacillin 250 mg, both belonging to the beta-lactam class of antibiotics. This formulation is indicated for the treatment of a wide range of bacterial infections caused by susceptible organisms, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, bone and joint infections, and septicemia. Ampicillin exhibits a broad spectrum of activity against gram-positive and some gram-negative bacteria by inhibiting bacterial cell wall synthesis, while Cloxacillin is particularly effective against penicillinase-producing staphylococci, enhancing the overall efficacy of the combination. The dual action of these antibiotics helps in overcoming resistance mechanisms and provides synergistic antibacterial effects. Megaclox Capsule should be administered as prescribed by a healthcare professional, with dosage adjusted according to the severity of infection, patient age, and renal function. It is contraindicated in patients with known hypersensitivity to penicillins or cephalosporins. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and hypersensitivity reactions like rash or urticaria. Caution is advised in patients with a history of allergy to beta-lactam antibiotics. Proper adherence to the prescribed regimen is essential to prevent the development of resistance and ensure therapeutic success.